ACH-806 - CAS 870142-71-5
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
ACH-806
Catalog Number:
870142-71-5
Synonyms:
GS-9132; N-(((4-(pentyloxy)-3-(trifluoromethyl)phenyl)amino)thioxomethyl)-3-Pyridinecarboxamide,
CAS Number:
870142-71-5
Description:
ACH-806 is a Hepatitis C virus NS3 protein inhibitor. It can inhibit viral RNA replication in HCV replicon cells and is active in genotype 1 HCV-infected patients in a proof-of-concept clinical trial. But Phase-II for Hepatitis C treatment was discontinued.
Molecular Weight:
411.45
Molecular Formula:
C19-H20-F3-N3-O2-S
Quantity:
Milligrams-Grams
Quality Standard:
In-house standard
COA:
Inquire
MSDS:
Inquire
Canonical SMILES:
CCCCCOc1ccc(cc1C(F)(F)F)NC(=S)NC(=O)c2cccnc2
InChI:
1S/C19H20F3N3O2S/c1-2-3-4-10-27-16-8-7-14(11-15(16)19(20,21)22)24-18(28)25-17(26)13-6-5-9-23-12-13/h5-9,11-12H,2-4,10H2,1H3,(H2,24,25,26,28)
InChIKey:
WJSGOXONRXFGRY-UHFFFAOYSA-N
Targets:
HCV
Current Developer:
Originator Achillion Pharmaceuticals

Related HCV Products


CAS 1206524-86-8 MK-5172 potassium salt

MK-5172 potassium salt
(CAS: 1206524-86-8)

In biochemical assays, MK-5172 was effective against a panel of major genotypes and variants engineered with common resistant mutations observed in clinical stu...

CAS 1000787-75-6 Tegobuvir

Tegobuvir
(CAS: 1000787-75-6)

Tegobuvir is a non-nucleoside nonstructural protein (NS)5B polymerase inhibitor.

CAS 630420-16-5 Asunaprevir

Asunaprevir
(CAS: 630420-16-5)

Asunaprevir is a potent hepatitis C virus (HCV) non-structural protein protease inhibitor currently in Phase III clinical trials for the treatment of HCV infect...

Vedroprevir
(CAS: 1098189-15-1)

Vedroprevir is a selective hepatitis C virus (HCV) NS3 protease inhibitor. It is a pharmaceutical drug that is used in the treatment of hepatitis C virus in pat...

Ravidasvir HCl
(CAS: 1303533-81-4)

Avidasvir is a second-generation Hepatitis C virus NS 5 protein inhibitor. In Sep 2016, Phase-II/III clinical trials in Hepatitis C in Malaysia was on-going.

CAS 394730-60-0 Boceprevir

Boceprevir
(CAS: 394730-60-0)

An NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection.

CAS 850876-88-9 Danoprevir

Danoprevir
(CAS: 850876-88-9)

Danoprevir(ITMN-191;R7227; RO5190591;RG7227) is a peptidomimetic inhibitor of the NS3/4A protease of hepatitis C virus (HCV) with IC50 of 0.2-3.5 nM, inhibition...

CAS 20724-73-6 2'-C-Methylcytidine

2'-C-Methylcytidine
(CAS: 20724-73-6)

2'-C-Methylcytidine, also called as NM107, inhibits the replication of HCV RNA and exerts inhibitory activity and cytotoxicity against HCV 1b replicon cells (IC...

CAS 691852-58-1 Nesbuvir

Nesbuvir
(CAS: 691852-58-1)

Nesbuvir, a novel selective nonstructural protein 5B (NS5B) polymerase inhibitor, acts as candidate for HCV treatment. It was reduced across different isolates.

CAS 817204-33-4 PSI-6130

PSI-6130
(CAS: 817204-33-4)

PSI-6130 is a potent and selective inhibitor of HCV NS5B polymerase. It is metabolized to two pharmacologically active species in primary human hepatocytes.

CAS 1441674-54-9 Ledipasvir acetone

Ledipasvir acetone
(CAS: 1441674-54-9)

Against JFH1/3a-NS5A, DCV was more potent (EC(50) = 0.52 nM) than GS-5885 (EC(50) = 141 nM). DCV sensitivity was increased against JFH1/3a-NS5A-M28V (EC50 = 0.0...

CAS 1502655-48-2 Ledipasvir diacetone

Ledipasvir diacetone
(CAS: 1502655-48-2)

Against JFH1/3a-NS5A, DCV was more potent (EC(50) = 0.52 nM) than GS-5885 (EC(50) = 141 nM). DCV sensitivity was increased against JFH1/3a-NS5A-M28V (EC50 = 0.0...

CAS 478182-28-4 R-1479

R-1479
(CAS: 478182-28-4)

R1479 is a potent and highly specific inhibitor of HCV replication in cell culture, and that its triphosphate is a potent and highly selective inhibitor of NS5B...

CAS 1200133-34-1 VCH-916

VCH-916
(CAS: 1200133-34-1)

VCH-916 is a novel allosteric inhibitor of HCV NS5B polymerase. The RNA-dependent RNA polymerase (NS5B) of HCV is one of the attractive validated targets for de...

CAS 940908-79-2 R-7128

R-7128
(CAS: 940908-79-2)

R-7128 is a selective nucleoside analog inhibitor of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase, with activity across all HCV genotypes. It i...

Radalbuvir
(CAS: 1314795-11-3)

Radalbuvir is a Hepatitis C virus NS 5 protein inhibitor for the treatment of hepatitis C virus (HCV) infection developed by Gilead Sciences. In 2014, Gilead co...

CAS 1190307-88-0 sofosbuvir

sofosbuvir
(CAS: 1190307-88-0)

PSI-7977 is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investiga...

CAS 36791-04-5 Ribavirin

Ribavirin
(CAS: 36791-04-5)

Ribavirin is a guanosine (ribonucleic) analog used to stop viral RNA synthesis and viral mRNA capping, thus, it is a nucleoside inhibitor.

APC-6336
(CAS: 263870-19-5)

APC-6336 is a Hepatitis C virus NS3 protein inhibitor.

CAS 1132935-63-7 ABT-333

ABT-333
(CAS: 1132935-63-7)

ABT-333 is a non-nucleoside polymerase inhibitor currently under clinical trials for the treatment of Hepatitis C